Rephonic
Artwork for Lung Cancer Considered

Lung Cancer Considered

IASLC
Lung Cancer
Immunotherapy
Biomarker Testing
Early-Stage Non-Small Cell Lung Cancer
EGFR Mutation
Non-Smokers
Non-Small Cell Lung Cancer
Chemoimmunotherapy
Low-Dose CT Scans
EGFR Mutant Non-Small Cell Lung Cancer
Chemotherapy
Demographics Of Lung Cancer
National Lung Screening Trial
Targeted Therapy
Genetic Testing
Molecular Therapy
Central Nervous System Metastases
Adjuvant Therapy
Neoadjuvant Therapy
ASCO 2024

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 6,500 lung cancer specialists across all disciplines in over 100 cou... more

PublishesTwice weeklyEpisodes344Founded6 years ago
Number of ListenersCategory
Science

Listen to this Podcast

Artwork for Lung Cancer Considered

Latest Episodes

The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2025 in world ... more

The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2025 in world ... more

In this episode, recorded live in Spanish at WCLC 2025, Dr. Diego Carrillo reflects on his experiences as a junior faculty member at WCLC 2025. In conversation with host Dr. Narjust Florez, they discuss conference activities, research highlights, and... more

The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2025 in world ... more

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Dr. Gerina Reiter
A thoracic pulmonologist and thoracic oncologist at the Netherlands Cancer Institute, principal investigator in several clinical trials.
Netherlands Cancer Institute
Episode: FDA Approval: Zongertinib for HER2 Mutant NSCLC
Dr. Ivi Dagojjak
A thoracic medical oncologist from Mass General Hospital and associate professor of medicine at Harvard Medical School.
Mass General Hospital
Episode: FDA Approval: Zongertinib for HER2 Mutant NSCLC
Bryant Lin
Clinical Professor of Medicine at Stanford University, primary care physician, educator, and researcher with stage 4 EGFR mutant lung cancer.
Stanford University
Episode: Dr. Bryant Lin Teaching My Cancer
Dr. Christine Loevely
Associate Professor of Medicine at the Vanderbilt Ingram Cancer Center
Vanderbilt Ingram Cancer Center
Episode: AACR 2025 Highlights
Dr. Aldea
Visiting scientist at the Nafarva Cancer Institute, creator of the largest registry for RET-positive non-small cell lung cancer
Gustav Roussi
Episode: What You Should Know About RET-Positive NSCLC: Live from TexasLung25
Dr. Misty Shields
Medical thoracic oncologist and physician scientist focusing on small cell lung cancer.
University of Indiana
Episode: Excuse me, What? Top Recommendations for Effective Patient Communication: Live from TexasLung25
Dr. Eric Singhee
Thoracic medical oncologist specializing in patient education research and young onset lung cancers.
MD Anderson Cancer Center
Episode: Excuse me, What? Top Recommendations for Effective Patient Communication: Live from TexasLung25
Dr. Bertrand Rauti
Associate clinical professor and co-director of the Shum Microbiome Center
Université de Montreal
Episode: The Microbiome and Immunotherapy for Lung Cancer
Dr. Ariel El-Krieff
Thoracic oncologist and co-director of the Shum Microbiome Center
Université de Montreal
Episode: The Microbiome and Immunotherapy for Lung Cancer

Hosts

Dr. Narjust Florez
Co-Director of the Young Lung Cancer Program and Associate Director of the Cancer Care Equity Program, specializing in thoracic oncology and lung cancer treatment.
Dr. Stephen Liu
Host and leading figure in lung cancer considerations, promoting knowledge sharing in this field.

Reviews

4.7 out of 5 stars from 40 ratings
  • Episode on Immunotherapy

    Really enjoyed the conversation between these oncologist. They seem to be great doctors who really care for their patients are working for the best solutions they know of.

    It was also interesting to see their blind spots. The great thing about immunotherapy is slowly opening the door between integrative oncology and traditional oncology. These guys don’t get into it but they are asking the right questions.

    1) What can be combined with immunotherapy?

    2) What can be done to prevent side effec... more

    Apple Podcasts
    5
    TBobo
    United States3 years ago
  • Fantastic for doctors, nurses, patients

    Great conversations on all things lung cancer.

    Apple Podcasts
    5
    DrFLC
    United States5 years ago
  • :)

    great info!

    Apple Podcasts
    5
    yeoohaz
    United States5 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Some feedback emphasizes the importance of interdisciplinary dialogue, highlighting the potential for advancing treatment understanding and developing holistic care approaches.
Listeners appreciate the insightful conversations among healthcare professionals, noting their depth of knowledge and commitment to patient care.
The discussions are praised for their ability to bridge the gap between clinical practices and patient experiences, often shedding light on critical issues in lung cancer treatment.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#42
Poland/Science
Apple Podcasts
#107
Chile/Science
Apple Podcasts
#166
Spain/Science
Apple Podcasts
#185
Hong Kong/Science
Apple Podcasts
#217
Israel/Science
Apple Podcasts
#231
Mexico/Science

Talking Points

Recent interactions between the hosts and their guests.

FDA Approval: Zongertinib for HER2 Mutant NSCLC
Q: Where will we fit this agent if it gets approved when it comes to treatment sequencing for HER2?
If approved, Zongertinib would initially serve as a second-line treatment after first-line options including platinum-based chemotherapy.
FDA Approval: Zongertinib for HER2 Mutant NSCLC
Q: What therapies are we using for first and second line therapy?
Currently, the standard of care includes platinum-based chemotherapy with or without immunotherapy for first line, and Trastuzumab diruxetocan as a second-line targeted therapy.
Dr. Bryant Lin Teaching My Cancer
Q: What advice do you have for physicians who find themselves in similar situations?
Avoid fixating on survival statistics because they won't change what you do; instead, focus on living day-to-day.
Dr. Bryant Lin Teaching My Cancer
Q: Can you talk about how you reacted to your diagnosis?
Initially, I went through denial and thought it might be something like an unusual infection rather than cancer, but I accepted my diagnosis within a few weeks.
The Microbiome and Immunotherapy for Lung Cancer
Q: Bertrand, can we bring this back to lung cancer? What are the active areas of investigation in lung cancer for microbiome as a therapeutic?
We are studying FMT in the first-line setting for lung cancer, and investigating prebiotics and dietary interventions that positively affect the microbiome.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Lung Cancer Considered

What is Lung Cancer Considered about and what kind of topics does it cover?

This podcast focuses on the latest developments and research in lung cancer treatment, featuring expert insights into various therapies, patient experiences, and emerging clinical data. The discussions commonly revolve around personalized treatment options, including targeted therapies and immunotherapy, and they emphasize the importance of understanding the nuances of lung cancer types such as HER2-positive and EGFR mutant non-small cell lung cancer (NSCLC). The ability to combine scientific advancements with practical patient care, alongside the importance of communication between healthcare professionals and patients, is frequently highlighted. This series provides a unique blend of expert opinions, patient stories, and new research find... more

Where can I find podcast stats for Lung Cancer Considered?

Rephonic provides a wide range of podcast stats for Lung Cancer Considered. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Lung Cancer Considered and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Lung Cancer Considered get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Lung Cancer Considered, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Lung Cancer Considered?

Rephonic provides comprehensive predictive audience data for Lung Cancer Considered, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Lung Cancer Considered have?

To see how many followers or subscribers Lung Cancer Considered has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Lung Cancer Considered?

These podcasts share a similar audience with Lung Cancer Considered:

1. Lung Cancer Update
2. Two Onc Docs
3. Lung Cancer Considered
4. OncLive® On Air
5. Oncology Brothers: Practice-Changing Cancer Discussions

How many episodes of Lung Cancer Considered are there?

Lung Cancer Considered launched 6 years ago and published 344 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Lung Cancer Considered?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Lung Cancer Considered?

Rephonic pulls ratings and reviews for Lung Cancer Considered from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Lung Cancer Considered?

Rephonic provides full transcripts for episodes of Lung Cancer Considered. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Lung Cancer Considered?

Recent guests on Lung Cancer Considered include:

1. Dr. Gerina Reiter
2. Dr. Ivi Dagojjak
3. Bryant Lin
4. Dr. Christine Loevely
5. Dr. Aldea
6. Dr. Misty Shields
7. Dr. Eric Singhee
8. Dr. Bertrand Rauti

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days